TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+8.89%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.76B
AUM Growth
+$2.76B
(+4.8%)
Cap. Flow
-$102M
Cap. Flow
% of AUM
-3.69%
Top 10 Holdings %
Top 10 Hldgs %
47.95%
Holding
149
New
13
Increased
31
Reduced
24
Closed
14
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$28.7M |
| 2 |
Illumina
ILMN
|
$25.5M |
| 3 |
SHPG
Shire pic
SHPG
|
$25.1M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$22.3M |
| 5 |
HCA Healthcare
HCA
|
$13.9M |
Top Sells
| 1 |
Viatris
VTRS
|
$81.3M |
| 2 |
Alkermes
ALKS
|
$52M |
| 3 |
AET
Aetna Inc
AET
|
$36.3M |
| 4 |
AKRX
Akorn, Inc.
AKRX
|
$26.3M |
| 5 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$24.7M |
Sector Composition
| 1 | Healthcare | 88.47% |
| 2 | Real Estate | 3.59% |
| 3 | Financials | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $236M | 8.55% | 2,331,231 +109,800 | +5% | +$11.1M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $205M | 7.44% | 1,713,634 | – | – |
|
3
Biogen
BIIB
$19.4B
| $138M | 5.01% | 450,533 -16,650 | -4% | -$5.1M |
|
4
Vertex Pharmaceuticals
VRTX
$100B
| $130M | 4.72% | 1,033,503 +23,600 | +2% | +$2.97M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $128M | 4.64% | 409,586 +91,900 | +29% | +$28.7M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $121M | 4.41% | 636,805 | – | – |
|
7
Johnson & Johnson
JNJ
$427B
| $96.7M | 3.51% | 940,988 | – | – |
|
8
Incyte
INCY
$16.5B
| $95.5M | 3.46% | 880,461 | – | – |
|
9
Teva Pharmaceuticals
TEVA
$21.1B
| $87.6M | 3.18% | 1,334,237 -51,357 | -4% | -$3.37M |
|
10
Regeneron Pharmaceuticals
REGN
$61.5B
| $83.7M | 3.04% | 154,266 | – | – |
|
|
11
Illumina
ILMN
$15.8B
| $83.4M | 3.02% | 434,341 +133,000 | +44% | +$25.5M |
|
12
BioMarin Pharmaceuticals
BMRN
$11.2B
| $62.5M | 2.26% | 596,145 +25,668 | +4% | +$2.69M |
|
13
Pfizer
PFE
$141B
| $58.2M | 2.11% | 1,802,291 | – | – |
|
14
Amgen
AMGN
$155B
| $52.2M | 1.89% | 321,640 | – | – |
|
15
UnitedHealth
UNH
$281B
| $48.1M | 1.75% | 409,100 +96,500 | +31% | +$11.4M |
|
|
16
Alkermes
ALKS
$4.78B
| $40.5M | 1.47% | 510,444 -655,374 | -56% | -$52M |
|
17
Merck
MRK
$210B
| $36M | 1.3% | 681,097 | – | – |
|
|
SHPG
18
DELISTED
Shire pic
SHPG
| $35.2M | 1.28% | 171,813 +122,300 | +247% | +$25.1M |
|
|
MDVN
19
DELISTED
MEDIVATION, INC.
MDVN
| $32.3M | 1.17% | 667,300 +461,900 | +225% | +$22.3M |
|
20
Agilent Technologies
A
$35.7B
| $30.5M | 1.1% | 728,650 +93,000 | +15% | +$3.89M |
|
|
21
HCA Healthcare
HCA
$94.5B
| $30.3M | 1.1% | 448,488 +205,300 | +84% | +$13.9M |
|
|
22
Viatris
VTRS
$12.3B
| $28.7M | 1.04% | 531,252 -1,504,405 | -74% | -$81.3M |
|
23
Humana
HUM
$36.5B
| $23.1M | 0.84% | 129,300 | – | – |
|
24
Acadia Pharmaceuticals
ACAD
$4.38B
| $22.7M | 0.82% | 637,500 +75,000 | +13% | +$2.67M |
|
25
Molina Healthcare
MOH
$9.8B
| $20.9M | 0.76% | 347,901 | – | – |
|